Rebecca K. Viscusi

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele et al. · New England Journal of Medicine · 2016 · 555 citations · Full text

Medicine, Oncology, Pharmacology +13

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee et al. · New England Journal of Medicine · 2016 · 460 citations · Full text

Medicine, Oncology, Pharmacology +17

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

Douglas Yee, Angela DeMichele, Christina Yau et al. · JAMA Oncology · 2020 · 225 citations · Full text

Medicine, Oncology, Breast Oncology +15

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial

A. Jo Chien, Debasish Tripathy, Kathy S. Albain et al. · Journal of Clinical Oncology · 2020 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer

W. Fraser Symmans, Christina Yau, Yunn-Yi Chen et al. · JAMA Oncology · 2021 · 106 citations · Full text

Medicine, Oncology, Breast Oncology +16